In vitro Testing of Trichomonas vaginalis Drug Susceptibility: Evaluation of Minimal Lethal Concentration for Secnidazole that Correlates with Treatment Success.

Graves, Keonte J; Novak, Jan; Tiwari, Hemant; Secor, W Evan; Augostini, Peter; Muzny, Christina A

Graves, Keonte J; Novak, Jan; Tiwari, Hemant; Secor, W Evan; Augostini, Peter; Muzny, Christina A.

Afiliación

Graves KJ; Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL.
Novak J; Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL.
Tiwari H; Department of Biostatistics, School of Public Health, University of Alabama at Birmingham, Birmingham, AL.
Secor WE; Division of Parasitic Diseases and Malaria, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA.
Augostini P; Division of Parasitic Diseases and Malaria, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA.
Muzny CA; Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL.

Sex Transm Dis ; 2024 Apr 30.

Article en En | MEDLINE | ID: mdl-38687328

ABSTRACT

ABSTRACT

ABSTRACT We determined the in vitro minimum lethal concentration (MLC) of secnidazole (SEC) and assessed correlation with clinical susceptibility among T. vaginalis isolates obtained from 71 women, of whom 66 were successfully treated with this medication. An MLC ≤12.5 µg/ml correlated with clinical susceptibility in this study.

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Sex Transm Dis Año: 2024 Tipo del documento: Article País de afiliación: Albania

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google